Trials / Completed
CompletedNCT04774302
Correlation Between Hepatic Fibrosis and Cardiovascular Risk Evaluated by Non-invasive Tests in Patients With NAFLD
Study of Correlation Between Hepatic Fibrosis and Cardiovascular Risk Evaluated by Non-invasive Tests in Patients With Nonalcoholic Fatty Liver Disease
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 292 (actual)
- Sponsor
- Clinique Pasteur · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to examine the link between Non-Alcoholic Fatty Liver Disease (NAFLD) and cardiovascular diseases by studying the association between liver fibrosis degree and cardiovascular risk factors. The study would clarify the value and the role of the Coronary calcium score (CAC score) in the screening for coronary disease in this population at high cardiovascular risk.
Detailed description
Hepatic Fibrosis and Cardiovascular Risk are evaluated by non invasive tests
Conditions
Timeline
- Start date
- 2021-03-18
- Primary completion
- 2025-04-30
- Completion
- 2025-04-30
- First posted
- 2021-03-01
- Last updated
- 2026-03-06
Locations
2 sites across 1 country: France
Source: ClinicalTrials.gov record NCT04774302. Inclusion in this directory is not an endorsement.